# Data Sources

## Overview

This document describes all **Immuno-Oncology (IO)** and **RNA-based signature** datasets used throughout the distributed univariable analysis pipeline. Complete documentation ensures **reproducibility**, proper attribution, and transparency across all collaborating centers.

---

## Immuno-Oncology Data Sources

### RNA-Seq and Clinical Data

- **Name**: Immune Checkpoint Blockade - RNA-Seq, and Clinical data
- **URL**: [https://www.orcestra.ca/clinical_icb](https://www.orcestra.ca/clinical_icb)
- **Access Method**: Direct download or programmatic retrieval via API (if applicable)
- **Data Format**: MultiAssayExperiment and SummarizedExperiment in R (Bioconductor)
- **Citation**: [Bareche, Y., Kelly, D., Abbas-Aghababazadeh, F. et al., Annals of Oncology 2022](https://pubmed.ncbi.nlm.nih.gov/36055464/)

### Signatures Platform

- **Name**: SignatureSets: An R Package for RNA-Based Immuno-Oncology Signatures
- **Version**: v1.0
- **URL - IO Signatures**: [bhklab/SignatureSets](https://github.com/bhklab/SignatureSets) 
- **URL - TME Signatures** â€” [IOBR Project](https://github.com/IOBR/IOBR)  
- **Access Method**: Direct download or programmatic retrieval via API (if applicable)
- **Data Format**: rda, CSV (signatures, metadata)
- **Citation**: [Bareche, Y., Kelly, D., Abbas-Aghababazadeh, F. et al., Annals of Oncology 2022](https://pubmed.ncbi.nlm.nih.gov/36055464/)

---


## Key Clinical Variables

| Variable            | Description                                       | Format   | Example      |
|---------------------|---------------------------------------------------|----------|--------------|
| patientid           | Unique patient identifier                         | string   | GSE12345_P01 |
| age                 | Age at diagnosis                                  | integer  | 63           |
| sex                 | Biological sex                                    | factor   | M/F          |
| cancer_type         | Primary cancer type                               | string   | Melanoma     |
| histo               | Histological classification                       | string   | Melanoma     |
| treatment_type      | IO therapy category                               | string   | PD-1/PD-L1   |
| stage               | Tumor stage at diagnosis                          | string   | Stage II     |
| recist              | RECIST clinical response                          | factor   | CR/PR/SD/PD  |
| response            | Clinical benefit status (e.g., response)          | string   | R/NR         |
| survival_time_os    | Overall survival time (months)                    | numeric  | 21.3         |
| event_occurred_os   | Overall survival event (1 = death)                | binary   | 1            |
| survival_time_pfs   | Progression-free survival time (months)           | numeric  | 18.2         |
| event_occurred_pfs  | Progression-free survival event (1 = progression) | binary   | 1            |
| survival_unit       | Unit of survival time                             | string   | months       |

---
